Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity
Nowadays, leishmaniasis is still treated with outdated drugs that present several obstacles related to their high toxicity, long duration, parenteral administration, high costs and drug resistance. Therefore, there is an urgent demand for safer and more effective novel drugs. Previous studies indica...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
Elsevier
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/67681 |
| _version_ | 1793400403680821248 |
|---|---|
| author | Henriquez-Figuereo, A. (Andreina) Alcon, M. (Mercedes) Moreno, E. (Esther) Sanmartin-Grijalba, C. (Carmen) Espuelas, S. (Socorro) de-Lucio, H. (Héctor) Jiménez-Ruiz, A. (Antonio) Plano-Amatriain, D. (Daniel) |
| author_facet | Henriquez-Figuereo, A. (Andreina) Alcon, M. (Mercedes) Moreno, E. (Esther) Sanmartin-Grijalba, C. (Carmen) Espuelas, S. (Socorro) de-Lucio, H. (Héctor) Jiménez-Ruiz, A. (Antonio) Plano-Amatriain, D. (Daniel) |
| author_sort | Henriquez-Figuereo, A. (Andreina) |
| collection | DSpace |
| description | Nowadays, leishmaniasis is still treated with outdated drugs that present several obstacles related to their high toxicity, long duration, parenteral administration, high costs and drug resistance. Therefore, there is an urgent demand for safer and more effective novel drugs. Previous studies indicated that selenium compounds are promising derivatives for innovative therapy in leishmaniasis treatment. With this background, a new library of 20 selenocyanate and diselenide derivatives were designed based on structural features present in the leishmanicidal drug miltefosine. Compounds were initially screened against promastigotes of L. major and L. infantum and their cytotoxicity was evaluated in THP-1 cells. Compounds B8 and B9 were the most potent and less cytotoxic and were further screened for the intracellular back transformation assay. The results obtained revealed that B8 and B9 showed EC50 values of 7.7 µM and 5.7 µM, respectively, in L. major amastigotes, while they presented values of 6.0 µM and 7.4 µM, respectively, against L. infantum amastigotes. Furthermore, they exerted high selectivity (60 < SI > 70) towards bone marrow-derived macrophages. Finally, these compounds exhibited higher TryR inhibitory activity than mepacrine (IC50 7.6 and 9.2 µM, respectively), and induced nitric oxide (NO) and reactive oxygen species (ROS) production in macrophages. These results suggest that the compounds B8 and B9 could not only exert a direct leishmanicidal activity against the parasite but also present an indirect action by activating the microbicidal arsenal of the macrophage. Overall, these new generation of diselenides could constitute promising leishmanicidal drug candidates for further studies. |
| format | info:eu-repo/semantics/article |
| id | oai:dadun.unav.edu:10171-67681 |
| institution | Universidad de Navarra |
| language | eng |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oai:dadun.unav.edu:10171-676812023-12-22T08:40:03Z Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity Henriquez-Figuereo, A. (Andreina) Alcon, M. (Mercedes) Moreno, E. (Esther) Sanmartin-Grijalba, C. (Carmen) Espuelas, S. (Socorro) de-Lucio, H. (Héctor) Jiménez-Ruiz, A. (Antonio) Plano-Amatriain, D. (Daniel) Diselenide Leishmanicidal agents Selenocompounds Selenocyanate Trypanothione reductase Nowadays, leishmaniasis is still treated with outdated drugs that present several obstacles related to their high toxicity, long duration, parenteral administration, high costs and drug resistance. Therefore, there is an urgent demand for safer and more effective novel drugs. Previous studies indicated that selenium compounds are promising derivatives for innovative therapy in leishmaniasis treatment. With this background, a new library of 20 selenocyanate and diselenide derivatives were designed based on structural features present in the leishmanicidal drug miltefosine. Compounds were initially screened against promastigotes of L. major and L. infantum and their cytotoxicity was evaluated in THP-1 cells. Compounds B8 and B9 were the most potent and less cytotoxic and were further screened for the intracellular back transformation assay. The results obtained revealed that B8 and B9 showed EC50 values of 7.7 µM and 5.7 µM, respectively, in L. major amastigotes, while they presented values of 6.0 µM and 7.4 µM, respectively, against L. infantum amastigotes. Furthermore, they exerted high selectivity (60 < SI > 70) towards bone marrow-derived macrophages. Finally, these compounds exhibited higher TryR inhibitory activity than mepacrine (IC50 7.6 and 9.2 µM, respectively), and induced nitric oxide (NO) and reactive oxygen species (ROS) production in macrophages. These results suggest that the compounds B8 and B9 could not only exert a direct leishmanicidal activity against the parasite but also present an indirect action by activating the microbicidal arsenal of the macrophage. Overall, these new generation of diselenides could constitute promising leishmanicidal drug candidates for further studies. 2023-10-20T07:42:06Z 2023-10-20T07:42:06Z 2023 info:eu-repo/semantics/article https://hdl.handle.net/10171/67681 eng info:eu-repo/semantics/openAccess application/pdf Elsevier |
| spellingShingle | Diselenide Leishmanicidal agents Selenocompounds Selenocyanate Trypanothione reductase Henriquez-Figuereo, A. (Andreina) Alcon, M. (Mercedes) Moreno, E. (Esther) Sanmartin-Grijalba, C. (Carmen) Espuelas, S. (Socorro) de-Lucio, H. (Héctor) Jiménez-Ruiz, A. (Antonio) Plano-Amatriain, D. (Daniel) Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title | Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title_full | Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title_fullStr | Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title_full_unstemmed | Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title_short | Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| title_sort | next generation of selenocyanate and diselenides with upgraded leishmanicidal activity |
| topic | Diselenide Leishmanicidal agents Selenocompounds Selenocyanate Trypanothione reductase |
| url | https://hdl.handle.net/10171/67681 |
| work_keys_str_mv | AT henriquezfiguereoaandreina nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT alconmmercedes nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT morenoeesther nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT sanmartingrijalbaccarmen nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT espuelasssocorro nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT deluciohhector nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT jimenezruizaantonio nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity AT planoamatriainddaniel nextgenerationofselenocyanateanddiselenideswithupgradedleishmanicidalactivity |